In a Pharma Talk Radio interview, Marc Boutin – Chief Executive Officer of the National Health Council – explains what the ‘chronic care trifecta’ means for patients. “The ‘chronic care trifecta’ means that patients are looking for a clinical outcome in the context of their personal goals and their life circumstances. Every individual has a set of goals even at the end of life. Those goals really largely define what treatments are going to be most appropriate for you and your life circumstances has a huge impact on that.”
Healthcare is not just about medicine, but also about the way we live our lives.
“Nobody wants to be defined by their disease”, says Marilyn Metcalf, Senior Director, Benefit Risk Evaluation at GlaxoSmithKline.
“Each of us is a patient at some point, each of us is a caregiver once. We all have family members who are patients too. Healthcare is a much broader issue. As scientists we are taught to be more objective. As social scientists, we know that any kind of observation can affect the whole environment. Much more so with patients. As human beings, we are all social. So we need to have a much more human interaction with patients and see them as whole people.”
In the case of chronic diseases, often treatments focus on promoting length of life, longevity. In the video interview below, Marc Boutin, Chief Executive Officer at National Health Council, challenges this pattern and explains why it is important to start looking at how patients live with the disease instead:
“You may think that the symptom that is most important to one disease group is pain. But when you ask people with that condition, you find out that what’s really most important to them is fatigue. So if companies are shooting at the wrong symptom, they are making treatments that are not relevant to patients.”